BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35008794)

  • 1. Modulation by 17,20S(OH)
    Brown Lobbins ML; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Tuckey RC; Scott IO; Myers LK; Postlethwaite AE
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17,20S(OH)
    Brown Lobbins ML; Scott IO; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Patel TS; Myers LK; Postlethwaite AE
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
    Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
    Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients.
    Lapoirie J; Tran L; Piazza L; Contin-Bordes C; Truchetet ME; Bonnet F
    Sci Rep; 2021 Sep; 11(1):18011. PubMed ID: 34504265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
    Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
    J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice.
    Song Y; Zhu L; Li M
    Clinics (Sao Paulo); 2013 Oct; 68(10):1350-7. PubMed ID: 24212843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.
    Ciechomska M; O'Reilly S; Suwara M; Bogunia-Kubik K; van Laar JM
    PLoS One; 2014; 9(12):e115596. PubMed ID: 25549087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
    Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
    Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
    Fineschi S; Reith W; Guerne PA; Dayer JM; Chizzolini C
    FASEB J; 2006 Mar; 20(3):562-4. PubMed ID: 16410344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
    Brown Lobbins ML; Shivakumar BR; Postlethwaite AE; Hasty KA
    Clin Exp Immunol; 2018 Jan; 191(1):84-95. PubMed ID: 28884475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
    Jing J; Dou TT; Yang JQ; Chen XB; Cao HL; Min M; Cai SQ; Zheng M; Man XY
    Eur Cytokine Netw; 2015; 26(1):10-4. PubMed ID: 25990837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis.
    Arvia R; Margheri F; Stincarelli MA; Laurenzana A; Fibbi G; Gallinella G; Ferri C; Del Rosso M; Zakrzewska K
    Rheumatology (Oxford); 2020 Nov; 59(11):3526-3532. PubMed ID: 32556240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts.
    Tsou PS; Balogh B; Pinney AJ; Zakhem G; Lozier A; Amin MA; Stinson WA; Schiopu E; Khanna D; Fox DA; Koch AE
    Arthritis Res Ther; 2014; 16(5):411. PubMed ID: 25123250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
    François A; Chatelus E; Wachsmann D; Sibilia J; Bahram S; Alsaleh G; Gottenberg JE
    Arthritis Res Ther; 2013 Oct; 15(5):R168. PubMed ID: 24289101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts.
    Wasson CW; Ross RL; Wells R; Corinaldesi C; Georgiou IC; Riobo-Del Galdo NA; Del Galdo F
    Arthritis Res Ther; 2020 Dec; 22(1):286. PubMed ID: 33303026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
    Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
    Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo.
    Slominski A; Janjetovic Z; Tuckey RC; Nguyen MN; Bhattacharya KG; Wang J; Li W; Jiao Y; Gu W; Brown M; Postlethwaite AE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E298-303. PubMed ID: 23295467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization.
    Wang Z; Jinnin M; Nakamura K; Harada M; Kudo H; Nakayama W; Inoue K; Nakashima T; Honda N; Fukushima S; Ihn H
    Exp Dermatol; 2016 Feb; 25(2):131-6. PubMed ID: 26566700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
    Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.